TD Cowen notes that Dianthus (DNTH) has announced an earlier than anticipated “Go” decision for its Phase 3 CAPTIVATE study of claseprubart in CIDP following a Part A interim analysis that met the responder rate threshold. The firm, which views Dianthus as “a viable takeout target,” keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DNTH: